Inventor · disambiguated record
Benjamin Daelken
Also filed as: DAELKEN BENJAMIN
19 granted patents·5 pending applications·105 citations·filing 2008–2022
93Inventor score
Top patents by PatentIndex Score
24 records- 0188US8530637B2Optimized DNA sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteinsWELS WINFRIED S·Filed 2011·Granted Sep 10, 2013·16 cites·23 claims
- 0288US7887801B2Optimized DNA and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteinsTOPOTARGET GERMANY AG·Filed 2008·Granted Feb 15, 2011·19 cites·22 claims
- 0386US10117932B2Uses of immunoconjugates targeting CD138BIOTEST AG·Filed 2012·Granted Nov 6, 2018·7 cites·46 claims
- 0486US9011864B2Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugatesSCHULZ GREGOR·Filed 2008·Granted Apr 21, 2015·19 cites·18 claims
- 0583US8956607B2Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE)OSTERROTH FRANK·Filed 2010·Granted Feb 17, 2015·7 cites·15 claims
- 0682US9289509B2Uses of immunoconjugates targeting CD138OSTERROTH FRANK·Filed 2010·Granted Mar 22, 2016·10 cites·49 claims
- 0781US9446146B2Methods and agents for improving targeting of CD138 expressing tumor cellsDAELKEN BENJAMIN·Filed 2008·Granted Sep 20, 2016·10 cites·10 claims
- 0881US9221914B2Agents targeting CD138 and uses thereofKRAUS ELMAR·Filed 2008·Granted Dec 29, 2015·6 cites·10 claims
- 0980US12186391B2Treatment of severe community acquired pneumoniaBIOTEST AG·Filed 2022·Granted Jan 7, 2025·0 cites·26 claims
- 1077US9387261B2Immunoconjugates targeting CD138 and uses thereofKRAUS ELMAR·Filed 2008·Granted Jul 12, 2016·4 cites·18 claims
- 1175US8852871B2Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)OSTERROTH FRANK·Filed 2010·Granted Oct 7, 2014·3 cites·21 claims
- 1272US11517621B2Treatment of severe community acquired pneumoniaBIOTEST AG·Filed 2021·Granted Dec 6, 2022·0 cites·26 claims
- 1369US9334325B2Method for treating psoriasisOSTERROTH FRANK·Filed 2010·Granted May 10, 2016·2 cites·13 claims
- 1466US10918715B2Treatment of severe community acquired pneumoniaBIOTEST AG·Filed 2020·Granted Feb 16, 2021·0 cites·23 claims
- 1564US9995733B2Agents for treating diseaseOSTERROTH FRANK·Filed 2012·Granted Jun 12, 2018·1 cites·28 claims
- 1661US9605066B2Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)BIOTEST AG·Filed 2014·Granted Mar 28, 2017·0 cites·14 claims
- 1759US9550831B2Method for treating psoriasisAIGNER SILKE·Filed 2010·Granted Jan 24, 2017·1 cites·13 claims
- 1856US2019117770A1Uses of immunoconjugates targeting cd138BIOTEST AG·Filed 2018·Application pending·0 cites
- 1952US9540436B2Use of antibodies for detection of IL-10BIOTEST AG·Filed 2015·Granted Jan 10, 2017·0 cites·14 claims
- 2052US2019076523A1Treatment of severe community acquired pneumoniaBIOTEST AG·Filed 2017·Application pending·0 cites
- 2143US2017081418A1Immunoconjugates targeting cd138 and uses thereofBIOTEST AG·Filed 2016·Application pending·0 cites
- 2241US2016185854A1Agents targeting cd138 and uses thereofBIOTEST AG·Filed 2015·Application pending·0 cites
- 2334US2011229465A1Composition for treating diseaseOSTERROTH FRANK·Filed 2011·Application pending·0 cites
- 2430US9512226B2Agent for treating diseaseGERMER MATTHIAS·Filed 2010·Granted Dec 6, 2016·0 cites·34 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →